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1. Introduction 
The fluorescence quenching of quinacrine (QA) 
which occurs upon association of the dye with ener- 
gized membranes has been widely used as an indica- 
tion of the development of the energy-pool [l-5]. 
The mechanism of the fluorescence quenching has 
generally included a direct role for the membrane 
[ 1,6-l 01, while simple diffusion of the diamine into 
the vesicle in response to the ApH cannot accurately 
account for the fluorescence quenching [ 11,121. Fur- 
thermore, photoaffinity labeling studies [ 131 have 
suggested that QA interacts with specific hydropho- 
bic sites on the energized membranes, possibly in a 
fashion similar to local anesthetics [14]. 
acts as a calcium antagonist displacing Ca*+ from its 
binding sites on calmodulin [ 171. This report demon- 
strates that 2 local anesthetics can effectively inhibit 
the energy-linked fluorescence quenching of QA with 
submitochondrial membranes. This effect is seen 
most effectively with chlorpromazine (CP) and to a 
lesser extent, butacaine (BC), while other anesthetics 
tested had no effect. The effect is not, however, due 
to any uncoupling effect of the anesthetic. 
2. Materials and methods 
Quinacrine is structurally analogous to local anes- 
thetics. As such, it exhibits several pharmacological 
properties in common with these anesthetic amines 
[ 15,161. Like a typical anesthetic, in vivo QA blocks 
the response of Electrophorous electricus, electro- 
plaque, in a noncompetitive manner, in vitro QA 
enhances the affinity of the choline@ receptor of 
Torpedo mamorato membrane fragments fo; acetyl 
choline. Quantitative studies on QA binding have 
indicated that there is a competition between QA and 
local anesthetics for the binding sites. Further, QA 
Submitochondrial particles (SMP) from heavy beef 
heart mitochondria were prepared as in [18,19]. The 
particles were treated with oligomycin (1 I.cg/mg pro- 
tein), malonate, and suspended in 0.25 M sucrose to 
25 mg protein/ml. NADH oxidase was measured with 
a Clark oxygen electrode in a medium consisting of 
150 mM sucrose, 30 mM phosphate (pH 7.4) and 
1 .O mM NADH at 25°C. 
Fluorescence measurements were made with a 
SLM fluorescence spectrophotometer (model 4000) 
interfaced with a data processor (HP 98 15A). The 
measurements were routinely obtained using an exci- 
tation slit of 4 nm and an emission slit of 8 nm. 
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9ACMA, 9-amino-3-chloro-7-methoxyacridine; BC, butacaine; 
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Scatchard analysis of QA bound to the membrane 
indicates that CP competes with QA for the binding 
sites on the energized membrane. This competitive 
binding study (not shown) was done by a rapid filtra- 
tion method using Millipore mixed cellulose-nitrate- 
acetate and cellulose-acetate (0.2 pm diam.) filters. 
However, 1 O-20% of the QA bound to these filters in 
the absence of the membranes, thereby making the 
determination of competitive-type inhibition difficult. 
Centrifugation was not considered an appropriate 
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alternative. While it seems clear that QA and CP are 
competitive other methods for a more accurate deter- 
mination will need to be developed. 
Quinacrine .2 HCl, chlorpromazine . HCl, tetra- 
Caine - HCl, procaine, lidocaine and butacaine hemi- 
sulfate were obtained from Sigma Chemical Co. All 
other chemicals were of the highest purity available 
commercially. Glass-redistilled water was used 
throughout. 
3. Results and discussion 
Fig.1 shows the inhibition of the energy-linked 
fluorescence response of QA upon the addition of CP. 
With increasing concentrations of CP, the extent of 
the response continually decreased until it eventually 
disappeared. This effect was independent of the order 
of addition; addition of CP while the membranes 
were energized had the same effect in releasing the 
fluorescence quenching (not shown). The equal cycle 
time of the fluorescence quenching induced upon the 
addition of 46 PM NADH in the absence and pres- 
ence of CP indicates that CP is not uncoupling the 
membrane. 
Butacaine (BC) also inhibits the energy-linked 
fluorescence response of QA but not as effectively as 
CP. Fig.2 shows the titration curve of the inhibition 
of the energy-linked fluorescence response of QA 
with both CP and BC. Clearly, an -IO-times greater 
concentration of BC was required to get the same 
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Fig.1. The effect of chlorpromazine on the energy-linked 
fluorescence decrease of QA. The reaction mixture consisted 
of 1.50 mM sucrose, 30 mM phosphate (pH 7.4) and 0.13 mg 
SMP protein/ml. Total vol. 3.0 ml. Other additions are as 
indicated. The fluorescence was measured with 420 nm exci- 
tation and 500 nm emission wavelength. T = 25°C. 
Fig.2. Titration of the energy-linked fluorescence response of 
QA with chlorpromazine (CP) and butacaine (BC). The con- 
ditions are as in fig.1. The app. Ki is the concentration of 
anesthetic which gives 50% inhibition of the energy-linked 
fluorescence response. 
effect as with CP. The apparent Ki for CP is 1.5 PM, 
which is comparable to the Kd (2.2 MM) of QA [ 11. 
The app. Ki of BC, however, is close to 10 PM. Thus, 
CP, but not BC, binds to the membrane with a higher 
affinity than QA. 
Other local anesthetics tested, such as lidocaine, 
procaine and tetracaine, have little or no effect on the 
fluorescence response of QA. This indicates that the 
inhibition with CP and BC is not caused simply by 
charge repulsions with molecules absorbed to the sur- 
face of the membrane. The selectivity of the inhibi- 
tion of the fluorescence response of QA indicated 
that there are stringent structural requirements for 
the binding sites. Indeed, there are considerable struc- 
tural similarities between CP and QA, while the other 
anesthetics differ considerably. 
Fig.3 shows the effect of CP and BC on NADH 
oxidase activity. Both CP and BC inhibited state 3 
and, to a lesser extent, state 4 respiration. Under these 
conditions, however, neither anesthetic stimulated 
state 4 respiration. In the case of CP, in the concen- 
tration range which inhibited the energy-linked fluo- 
rescence response (<lo PM), there was no significant 
effect on the rate of either state 3 or 4 respiration. 
Although with BC there was considerable inhibition 
of state 3 respiration, state 4 respiration was not 
inhibited to an extent which would explain the release 
of the fluorescence quenching of QA. Thus, the inhi- 
bition of the energy-linked fluorescence response of 
QA by both BC and CP was not due to any uncoupling 
activity ascribable to the anesthetics. 
The effect of CP on the energy-linked response 
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Fig.3. The inhibition of NADH oxidase by CP (A) and BC (B). The activities were measured in the presence (0) (state 3) and 
absence (0) (state 4) of FCCP (3.3 wM). The reaction mixture consisted of 150 mM sucrose, 30 mM phosphate (pH 7.4), 166 mM 
NaSCN and 0.13 mg SMP protein/ml. Total vol. 1.0 ml; Z’= 25“C. 
presented in this paper is much greater than that with 
chloroplast membranes, as in [3]. With 22 PM chlor- 
promazine, 50% inhibition of the response was seen 
when using -10 PM QA and less inhibition was seen 
with the lower concentrations of QA. In [3], however, 
the inhibition of the fluorescence response was inter- 
preted to be due to an uncoupling effect of CP. This 
was not the cause of the inhibition of the fluorescence 
response with SMP (cf. below) and furthermore, does 
not explain the large difference seen in the effective- 
ness of CP with SMP relative to that with chloroplast. 
The cause for the smaller effect on the fluorescence 
response in chloroplast membranes is moot, but it 
may be due to differences in both the number and 
the type of binding sites. Since chloroplast membranes 
are composed of primarily neutral lipids [20] and 
much less protein the number of the binding sites 
may be expected to be much greater. Furthermore, 
with the absence of the charged phosphate groups of 
the lipids, the binding forces would be primarily 
hydrophobic and steric. 
These results support the contention that there are 
specific binding sites for QA with the membrane. The 
question arises as to the significance of these sites and 
their relation to the energy-pool. Although only spec- 
ulative, the sites may be a reflection of changes in the 
membrane which are required for ATP synthesis, such 
as an ordering and dehydration of the membrane lipids. 
Our recent results indicate that the effect seen 
with these local anesthetics on the fluorescence 
response of QA is also seen with 9-aminoacridine 
(9AA) and 9-amino-6-chloro-2-methoxyacridine 
(9ACMA), though to different extents. These data are 
in line with [21] that there are specific binding sites 
for 9AA and 9ACMA with the membrane. If this 
were the case, then the ApH determinations made 
with these probes will be severely overestimated. These 
determinations have always assumed that there were 
no interactions between the membrane and the probe 
[22]. The validity of this assumption should, there- 
fore, be reevaluated. Indeed, such interactions may 
also occur between the membrane and the other 
amines, e.g. methylamine and ammonia. 
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